STAAR reports $8 million net loss in first quarter
STAAR Surgical reported a net loss of $8 million, or $0.20 per share, in the first quarter compared with a net loss of $2.3 million, or $0.06 per share, in the same quarter of 2015, according to a company press release.
Net sales increased 2% over the previous year’s first quarter, and was reported at $19.3 million. The increase in sales was attributed mostly to increased sales of the Visian ICL in China and Germany.
Operating expenses were reported at $23 million compared with $14.4 million in the same quarter of 2015.
Cash and cash equivalents totaled $9 million, down from $10.8 million in the same quarter of 2015.